Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial
Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision label from v3.6.3 to v3.6.4, indicating a software revision. It does not alter the study details or other visible content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now shows a new revision indicator: v3.6.3, replacing the previous v3.6.0. This signals a software update to the site portal rather than a change to the trial content presented.SummaryDifference0.1%

- Check54 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', indicating the study is not recruiting. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was standardized with a revision update from v3.5.5 to v3.6.0.SummaryDifference0.7%

- Check61 days agoChange DetectedThe page displays Revision: v3.5.5, replacing v3.5.4, indicating a background update to the page rather than changes to the study information.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's version. This change reflects metadata, not new study content or user-facing features.SummaryDifference0.1%

- Check104 days agoChange DetectedThis updates the ClinicalTrials.gov page viewer/version label from **v3.5.2** to **v3.5.3**, reflecting a site or template revision without changing the underlying study information.SummaryDifference0.1%

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.